Bildgebende Verfahren bei Myokarditis und Kardiomyopathie

Zusammenfassung

Dieser Artikel bietet eine Übersicht über aktuelle Bildgebungstechniken bei Diagnostik und Management von Patienten mit Myokarditis und Kardiomyopathien: von CT über kardiovaskuläre MRT bis hin zu Hybridtechniken.

Abstract

This manuscript gives a comprehensive overview with regard to cardiac imaging techniques for work-up and management of patients with myocarditis or cardiomyopathies.

Schlüsselwörter

Bildgebung - Myokarditis - Kardiomyopathie - CMR

Keywords

Imaging - myocarditis - cardiomyopathy - CMR

• Literatur

• 1 Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation 2006; 113: 876-890
• 2 Redheuil AB, Azarine A, Garrigoux P, Mousseaux E. Images in cardiovascular medicine. Correspondence between delayed enhancement patterns in multislice computed tomography and magnetic resonance imaging in a case of acute myocarditis. Circulation 2006; 114: e571-572
• 3 Abdel-Aty H, Boyé P, Zagrosek A et al. Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. J Am Coll Cardiol 2005; 45: 1815-1822
• 4 Gutberlet M, Spors B, Thoma T et al. Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence. Radiology 2008; 246: 401-409
• 5 Grün S, Schumm J, Greulich S et al. Long-term follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery. J Am Coll Cardiol 2012; 59: 1604-1615
• 6 Schumm J, Greulich S, Wagner A et al. Cardiovascular magnetic resonance risk stratification in patients with clinically suspected myocarditis. J Cardiovasc Magn Reson 2014; 16: 14
• 7 Friedrich MG, Sechtem U, Schulz-Menger J et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009; 53: 1475-1487
• 8 Florian A, Schäufele T, Ludwig A et al. Diagnostic value of CMR in young patients with clinically suspected acute myocarditis is determined by cardiac enzymes. Clin Res Cardiol 2015; 104: 154-163
• 9 le Polain de Waroux JB, Pouleur AC, Goffinet C et al. Combined coronary and late-enhanced multidetector-computed tomography for delineation of the etiology of left ventricular dysfunction: comparison with coronary angiography and contrast-enhanced cardiac magnetic resonance imaging. Eur Heart J 2008; 29: 2544-2551
• 10 Koiwa H, Tsujino I, Ohira H et al. Images in cardiovascular medicine: Imaging of cardiac sarcoid lesions using fasting cardiac 18F-fluorodeoxyglucose positron emission tomography: an autopsy case. Circulation 2010; 122: 535-536
• 11 McMurray JJ, Adamopoulos S, Anker SD et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012; 33: 1787-1847
• 12 Bruder O, Wagner A, Lombardi M et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry – multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson 2013; 15: 9
• 13 Green JG, Berger J, Kramer CM, Salerno M. Prognostic value of cardiac magnetic resonance late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. JACC Cardiovasc Imaging 2012; 5: 370-377
• 14 Bruder O, Wagner A, Jensen CJ et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010; 56: 875-887
• 15 Gersh BJ, Maron BJ, Bonow RO et al. 2011 ACCF / AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: 2761-2796
• 16 Greulich S, Deluigi CC, Gloekler S et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013; 6: 501-511
• 17 Klem I, Shah DJ, White RD et al. Prognostic value of routine cardiac magnetic resonance assessment of left ventricular ejection fraction and myocardial damage: an international, multicenter study. Circ Cardiovasc Imaging 2011; 4: 610-619
• 18 Rapezzi C, Arbustini E, Caforio AL et al. Diagnostic work-up in cardiomyopathies: bridging the gap between clinical phenotypes and final diagnosis. A position statement from the ESC Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34: 1448-1458